Previous studies have shown that WT1 expression levels increase as the MDS disease stage progresses, in accordance with IPSS [22, 23], the World Health Organization’s classification-based Prognostic Scoring System (WPSS) [24], and the revised IPSS (IPSS-R) [25]. This evidence concerns the gene WT1 and myelodysplastic syndrome.